Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Novagali Pharma.
Recruitment status was  Active, not recruiting
Study NCT00665106   Information provided by Novagali Pharma

First Received on April 22, 2008.   Last Updated on July 15, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Macular Edema
Additional conditions recognized in this trial
Diabetic Retinopathy
Edema
Macular Edema
Retinal Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Endocrine System Diseases
Eye Diseases
Macular Degeneration
Retinal Degeneration
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
NOVA63035 "Corticosteroid"
Sponsors listed in this trial
Novagali Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services